Get started
Work

Effects of HER2 immuno-histochemistry expression levels on survival in patients treated by trastuzumab at the adjuvant setting in the SIGNAL/PHARE prospective cohort

Year: 2016
Type: article
DOI: 10.1093/annonc/mdw364.40
Authors: E. Curtit, A. Vincent-Salomon, S. Paget-Bailly, G. Romieu, P. Fumoleau, H. Bonnefoi, C. Jouannaud, T. Petit, A. Darut-Jouve, V. Trillet-Lenoir, C. Tarpin, J.-Y. Pierga, M. Rios, J.P. Jacquin, T. Bachelot, D. Cox, J.-F. Deleuze, I. Pauporte, J. Henriques, X. Pivot
Institutions: Centre Hospitalier Universitaire de Besançon, Institut Curie, Institut de Recherche en Cancérologie de Montpellier, Institut Regional du Cancer de Montpellier, Centre Georges François Leclerc, Institut Bergonié, Institut Jean Godinot, Institut Strauss, Hôpital Lyon Sud, Institut Paoli-Calmettes, Institut de Cancérologie de Lorraine, Institute Cancer De La Loire Lucien Neuwirth, Centre Léon Bérard, Inserm, Fondation Jean Dausset-CEPH, Institut National du Cancer
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2588603370
FWCI:
Cites:
Cited by:
Related to: 10